Real-world clinical burden among patients with and without heart failure worsening after cardiac resynchronization therapy

References

• Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11.
   PubMedGoogle Scholar
• McMurray JJV, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787–1847.
   PubMed Web of Science ®Google Scholar
• McAloon DCJ, Theodoreson DMD, Hayat DS, et al. Cardiac resynchronization therapy and its role in the management of heart failure. Br J Hosp Med. 2017;78(6):312–319.
   Web of Science ®Google Scholar
• Albouaini K, Egred M, Rao A, et al. Cardiac resynchronisation therapy: evidence based benefits and patient selection. Eur J Intern Med. 2008;19(3):165–172.
   PubMed Web of Science ®Google Scholar
• Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344(22):1651–1658.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137–e161.
   PubMed Web of Science ®Google Scholar
• van der Meer P, Gaggin HK, Dec GW. ACC/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J Am Coll Cardiol. 2019;73(21):2756–2768.
   PubMed Web of Science ®Google Scholar
• Rossi A, Rossi G, Piacenti M, et al. The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials. Heart Vessels. 2008;23(4):217–223.
   PubMed Web of Science ®Google Scholar
• Cooper LB, DeVore AD, Michael Felker G. The impact of worsening heart failure in the United States. Heart Fail Clin. 2015;11(4):603–614.
   PubMed Web of Science ®Google Scholar
• DeVore Adam D, Hammill Bradley G, Sharma Puza P, et al. In‐hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization. J Am Heart Assoc. 2014;3(4):e001088.
   PubMed Web of Science ®Google Scholar
• Sieniewicz BJ, Gould J, Porter B, et al. Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions. Heart Fail Rev. 2019;24(1):41–54.
   PubMed Web of Science ®Google Scholar
• Varma N, Boehmer J, Bhargava K, et al. Evaluation, management, and outcomes of patients poorly responsive to cardiac resynchronization device therapy. J Am Coll Cardiol. 2019;74(21):2588–2603.
   PubMed Web of Science ®Google Scholar
• Corbisiero R, Buck DC, Muller D, et al. What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population. J Interv Card Electrophysiol. 2016;47(2):189–195.
   PubMed Web of Science ®Google Scholar
• Choi Y, Byeon J, Jung MH, et al. Echocardiographic, electrocardiographic changes and clinical outcomes of patients who respond to cardiac resynchronization therapy after one year. J Cardiovasc Ultrasound. 2017;25(2):63–69.
   PubMedGoogle Scholar
• Chung ES, Rickard J, Lu X, et al. Real-World economic burden among patients with and without heart failure worsening after cardiac resynchronization therapy. Adv Ther. 2021;38(1):441–467.
   PubMed Web of Science ®Google Scholar
• Guidance regarding methods for de-identification of protected health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA) privacy rule; 2012.
   Google Scholar
• Chung Eugene S, Leon Angel R, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608–2616.
   PubMed Web of Science ®Google Scholar
• Lellouche N, De Diego C, Vaseghi M, et al. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation. Pacing Clin Electro. 2007;30(11):1363–1368.
   PubMed Web of Science ®Google Scholar
• Powell AC, Rogstad TL, Deshmukh UU, et al. An exploration of the association between ischemic etiology and the likelihood of heart failure hospitalization following cardiac resynchronization therapy. Clin Cardiol. 2017;40(11):1090–1094.
   PubMed Web of Science ®Google Scholar
• van 't Sant J, Fiolet ATL, ter Horst IAH, et al. Volumetric response beyond six months of cardiac resynchronization therapy and clinical outcome. PLOS One. 2015;10(5):e0124323.
   PubMed Web of Science ®Google Scholar
• Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–3679.
   PubMed Web of Science ®Google Scholar
• Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009;53(9):765–773.
   PubMed Web of Science ®Google Scholar
• Lunati M, Magenta G, Cattafi G, et al. Clinical relevance of systematic CRT device optimization. J Atr Fibrillation. 2014;7(2):1077–1077.
   PubMedGoogle Scholar
• Dauw J, Martens P, Mullens W. CRT optimization: what is new? What is necessary? Curr Treat Options Cardiovasc Med. 2019;21(9):45.
   PubMedGoogle Scholar
• Rickard J, Michtalik H, Sharma R, et al. Predictors of response to cardiac resynchronization therapy: a systematic review. Int J Cardiol. 2016;225:345–352.
   PubMed Web of Science ®Google Scholar
• Brugada J, Delnoy PP, Brachmann J, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017;38(10):730–738.
   PubMed Web of Science ®Google Scholar
• Ritter P, Delnoy PP, Padeletti L, et al. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace. 2012;14(9):1324–1333.
   PubMed Web of Science ®Google Scholar
• Martin DO, Lemke B, Birnie D, et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm. 2012;9(11):1807–1814.
   PubMed Web of Science ®Google Scholar
• Birnie D, Hudnall H, Lemke B, et al. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: results of the adaptive cardiac resynchronization therapy trial. Heart Rhythm. 2017;14(12):1820–1825.
   PubMed Web of Science ®Google Scholar
• Singh JP, Cha YM, Lunati M, et al. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: effect on mortality and atrial fibrillation incidence. J Cardiovasc Electrophysiol. 2020;31(4):825–833.
   PubMed Web of Science ®Google Scholar
• Stevenson WG, Hernandez AF, Carson PE, et al. Indications for cardiac resynchronization therapy: 2011 update from the heart failure society of America Guideline Committee. J Card Fail. 2012;18(2):94–106.
   PubMed Web of Science ®Google Scholar